References
- Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 1988;54:787–93.
- Koldas M, Uras F. Avidin-Biotin ELISA for measurement of prothrombin in human plasma. Thromb Res 2001;102:221–7.
- Uras F, Uras AR, Yardimci T, Sardana MK. Determination of the N-terminal amino acid sequence of the purified prothrombin from a patient with liver cirrhosis. Thromb Res 2000;99:277–83.
- Nakano T, Higashino K, Kikuchi N, et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca2+-mobilizing growth factors. J Biol Chem 1995;270:5702–5.
- Kucuk B, Ozakpinar OB, Demir M, Uras F. Growth Arrest-Specific 6 (Gas6) and TAM receptors in mouse platelets. Turk J Haematol 2015;32:58–63.
- Lai C, Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991;6:691–704.
- Shaul WL, Emery H, Hall JG. Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child 1975;129:360–2.
- Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–40.
- Antipatis C, Ashworth CJ, Grant G, et al. Effects of maternal vitamin A status on fetal heart and lung: changes in expression of key developmental genes. Am J Physiol 1998;275:1184–91.
- Nakano T, Kawamoto K, Higashino K, Arita H. Cell adhesion to phosphatidylserine mediated by a product of Growth Arrest-specific Gene 6. FEBS Lett 1996;387:78–80.
- Angelillo-Scherrer A, de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215–21.
- Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001;293:306–11.
- Borgel D, Clauser S, Bornstain C, et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006;34:219–22.
- Erek-Toprak A, Bingol-Ozakpinar O, Karaca Z, et al. Association of plasma growth arrest specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes. Ren Fail 2014;36:737–42.
- Suh CH, Hilliard B, Li S, et al. TAM receptor ligands in lupus: protein S but not GAS6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 2010;12:R146.
- Sunbul M, Cagman Z, Gerin F, et al. Growth arrest-specific 6 and cardiometabolic risk factors in patients with psoriasis. Cardiovasc Ther 2015;33:56–61.
- Ozakpinar OB, Sahin S, Verimli N, et al. Association between the growth arrest-specific 6 (Gas6) gene polymorphism c.834 + 7G > A and preeclampsia. J Matern Fetal Neonatal Med 2016;29:1149–53.
- Eroglu M, Ozakpinar OB, Turkgeldi L, et al. Plasma levels of growth arrest specific protein 6 are increased in idiopathic recurrent pregnancy loss. Eur Rev Med Pharmacol Sci 2014;18:1554–8.
- Ito M, Nakashima M, Nakayama T, et al. Expression of receptor-type tyrosine kinase, Axl, and its ligand, Gas6, in pediatric thyroid carcinomas around Chernobyl. Thyroid 2002;12:971–5.
- Hsiao FC, Lin YF, Hsieh PS, et al. Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents. J Clin Endocrinol Metab 2013;98:E267–74.
- Lindqvist PG, Balogh I, Dahlbäck B. Umbilical cord plasma levels of growth-arrest specific protein 6 in intrauterine growth restriction. Acta Obstet Gynecol Scand 2010;89:22–6.
- Ekman C, Linder A, Åkesson P, Dahlbäck B. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 2010;14:R158.
- Hurtado B, García de Frutos P. GAS6 in systemic inflammatory diseases: with and without infection. P Crit Care 2010;14:1003.
- Kliegman RM, Stanton B, St. Geme J, et al. Nelson textbook of pediatrics. 19th ed. Philadelphia, PA: Elsevier/Saunders; 2011.
- Almeida AC, Jesus AC, Lima PF, et al. Maternal risk factors for premature births in a public maternity hospital in Imperatriz. Rev Gaucha Enferm 2012;33:86–94.
- Jefferson KK. The bacterial etiology of preterm birth. Adv Appl Microbiol 2012;80:1–22.
- Cagman Z, Bingol Ozakpinar O, Cirakli Z, et al. Reference intervals for growth arrest-specific 6 protein in adults. Scand J Clin Lab Invest. 2017;77:109–14.
- Mumdzhiev H. The late preterm infants–time to put our mind. Akush Ginekol (Sofiia) 2012;51:38–45.
- Moore T, Hennessy EM, Myles J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012;345:e7961.
- van der Ham DP, Vijgen SM, Nijhuis JG, et al., PPROMEXIL trial group. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Med 2012;9:e1001208.